Back to Search
MATTHEW HARBISON, MD
MD
Hospitalist Physician
NPI: 1043223209Individual
Specialties, Licenses & Credentials
Research & Publications (11)
Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia.
PMID 15797962·J Clin Endocrinol Metab·2005
3-trial
A randomized crossover study to evaluate Ro 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist in women with stress urinary incontinence.
PMID 14678373·BJU Int·2004
3-trial
Haplotype analysis of the growth hormone releasing hormone receptor locus in three apparently unrelated kindreds from the indian subcontinent with the identical mutation in the GHRH receptor.
PMID 12794696·Am J Med Genet A·2003
8-other
Effects of the proteasome inhibitor PS-341 on apoptosis and angiogenesis in orthotopic human pancreatic tumor xenografts.
PMID 12516957·Mol Cancer Ther·2002
7-preclinical
Effect of the vascular endothelial growth factor receptor-2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice.
PMID 12385004·Int J Cancer·2002
7-preclinical
Meier-Gorlin syndrome: report of eight additional cases and review.
PMID 11477602·Am J Med Genet·2001
5-case
Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia.
PMID 11297576·J Clin Endocrinol Metab·2001
8-other
Osteoporosis: an unusual presentation of childhood Crohn's disease.
PMID 10852438·J Clin Endocrinol Metab·2000
5-case
Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma.
PMID 10850439·Cancer Res·2000
7-preclinical
Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.
PMID 10815919·Clin Cancer Res·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 6431 FANNIN ST, MSB 1.122
HOUSTON, TX 77030 - Phone
- (713) 500-6714
Quick Facts
- NPI
- 1043223209
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 4
- Locations
- 3
- Publications
- 11
Are you this provider?
Claim Your Profile